Measurements: Difference between revisions
An Avatar.Global Resource
Created page with ""Spielberger's State‐Trait Anxiety Inventory‐Global (STAI‐G) score" <ref>“LSD Reduces Anxiety Symptoms in Phase 2 Trial.,” ''Brown University Psychopharmacology Upda..." |
No edit summary |
||
| Line 1: | Line 1: | ||
==Notes== | |||
Søndergaard et al. provide a list of instruments devoted to measuring [[Connection Outcome]]s.<ref>Anna Søndergaard, Martin Korsbak Madsen, Brice Ozenne, Sophia Armand, Gitte Moos Knudsen, Patrick MacDonald Fisher, and Dea Siggaard Stenbæk. “Lasting Increases in Trait Mindfulness after Psilocybin Correlate Positively with the Mystical-Type Experience in Healthy Individuals.” Frontiers in Psychology 13 (October 1, 2022). https://doi.org/10.3389/fpsyg.2022.948729</ref> | |||
"Spielberger's State‐Trait Anxiety Inventory‐Global (STAI‐G) score" <ref>“LSD Reduces Anxiety Symptoms in Phase 2 Trial.,” ''Brown University Psychopharmacology Update'' 34, no. 1 (January 2023): 2, <nowiki>https://doi.org/10.1002/pu.30965</nowiki>.</ref> | "Spielberger's State‐Trait Anxiety Inventory‐Global (STAI‐G) score" <ref>“LSD Reduces Anxiety Symptoms in Phase 2 Trial.,” ''Brown University Psychopharmacology Update'' 34, no. 1 (January 2023): 2, <nowiki>https://doi.org/10.1002/pu.30965</nowiki>.</ref> | ||
{{endstuff}} | |||
Revision as of 14:49, 22 January 2023
Notes
Søndergaard et al. provide a list of instruments devoted to measuring Connection Outcomes.[1]
"Spielberger's State‐Trait Anxiety Inventory‐Global (STAI‐G) score" [2]
Citation and Legal
Treat the SpiritWiki as an open-access online monograph or structured textbook. You may freely use information in the SpiritWiki; however, attribution, citation, and/or direct linking are ethically required.
Footnotes
- ↑ Anna Søndergaard, Martin Korsbak Madsen, Brice Ozenne, Sophia Armand, Gitte Moos Knudsen, Patrick MacDonald Fisher, and Dea Siggaard Stenbæk. “Lasting Increases in Trait Mindfulness after Psilocybin Correlate Positively with the Mystical-Type Experience in Healthy Individuals.” Frontiers in Psychology 13 (October 1, 2022). https://doi.org/10.3389/fpsyg.2022.948729
- ↑ “LSD Reduces Anxiety Symptoms in Phase 2 Trial.,” Brown University Psychopharmacology Update 34, no. 1 (January 2023): 2, https://doi.org/10.1002/pu.30965.